In conclusion, our results demonstrate that the tumor growth of an engineered xenograft breast cancer model with an HA-accumulating stroma is dependent on HA and independent of CD44, suggesting that HA-CD44 interaction may not be the main mechanism through which HA promotes tumor growth in certain tumors. The gene discussed is CD44; the disease is breast cancer.